Ersa, NCT05454956: Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD |
|
|
| Completed | 2 | 40 | US | TP-03, TP-03 Vehicle | Tarsus Pharmaceuticals, Inc. | Meibomian Gland Dysfunction, Blepharitis, Demodex Infestation | 05/23 | 05/23 | | |